Last year Petplan received over 31,000 nominations across the five award categories: Practice of the Year, Vet of the Year, Vet Nurse of the Year, Practice Manager of the Year and Practice Support Staff of the Year.
The awards are judged by an independent panel which narrows the field to three finalists in each category, who are then invited to attend the awards ceremony.
The judges are looking for examples of exceptional levels of animal care, building and sustaining great relationships with colleagues and pet owners, and those who have gone above and beyond the call of duty.
James Barnes, Head of Sales & Partnerships at Petplan, said: “The Petplan Veterinary Awards provide the perfect opportunity to say thank you for the exceptional work carried out by members of the veterinary profession, whatever their field and wherever they’re based. The Petplan Vet Awards provide a great opportunity for both clients and colleagues to recognise the dedication and talent of veterinary professionals, teams and practices, right across the UK and say a particular thank you to those who have kept up the exceptional level of care even in the midst of a global crisis."
To nominate a colleague or your practice, visit www.petplan.co.uk before nominations close on 10th January 2022.
SureFlap, a microchip pet product company, will be launching SureFeed, a new automatic cat feeder at the London Vet Show, Stand L32, on the 21st - 22nd November 2013.
The company, which already sells a range of microchip-operated pet doors, says the new products are designed to keep food fresh and the kitchen free of smells and flies.
SureFeed will be available in two models: the SureFeed Pet Feeder, which opens when any pet approaches, and the SureFeed Microchip Pet Feeder which in addition functions as a selective pet feeder that opens only when it identifies a cat with a registered microchip or RFID collar tag.
Both products feature a bowl which seals shut to keep wet food fresh.
Dr Nick Hill, inventor of SureFeed as well as founder and inventor of SureFlap says this is an exciting new development for the company: "Many cats are fussy eaters and prefer to eat food when it is fresh, others are on special diets and this can be a problem in multi-pet households. Even in households where each cat is on the same diet, a 'greedy' cat, or even dog, can eat most of the food. This can result in one pet becoming overweight while the other starts to lose condition. The SureFeed product range has been designed to address all these issues."
The SureFeed Microchip Pet Feeder recognises a cat's unique microchip number and when an authorised cat is present, the sealed lid over the bowl slides back to reveal the food. Once the cat has left the feeder, the lid slides back over the bowl. The SureFeed Pet Feeder features the same sealed lid which is triggered to open by any approaching pet, closing again when the pet has finished feeding.
Nick said: "The SureFeed product range is the culmination of two years' intensive development work. The feeders incorporate a number of features to maximise usability, such as the Microchip Pet Feeder's side guards and lid which folds up to the rear, which shield the food from other pets while the authorised cat is eating. The feeders are both easy to wipe clean and the food bowl, mat and lid can be removed and are dishwasher-safe.
"The SureFeed Pet Feeder and Microchip Pet Feeder are the first in a suite of pet feeding products from SureFlap incorporating sealed operation and flexible feeding options and we are looking forward to developing the range in the future."
SureFeed products will be available to order from early 2014 but in the meantime, you can see them in action at Stand L32 at the London Vet Show.
Cryptisel is for use in reducing oocyst shedding in calves where diarrhoea caused by Cryptosporidium is a problem. After the presence of the causal organism has been established, Forte says Cryptisel can be used in all new-born calves to break the cycle of transmission and multiplication on-farm.
Dr John Henderson, Large Animal Product Manager with Forte Healthcare Ltd said: "Cryptisel will be a very useful medicine in the control of the most commonly-identified scour pathogen in the UK and Ireland. Used alongside the calf-rearing cornerstones of good colostrum management, hygiene, and biosecurity, Cryptisel will reduce production of Cryptosporidium oocysts and help limit spread of the disease among susceptible calves."
Cryptisel is a POM, available in 490ml and 980ml bottles. Both sizes come with a metered dosing pump for convenient administration.
For further information, contact your local Forte Territory Manager or email enquiries@fortehealthcare.com.
MDC Exports is launching a cat cage at BSAVA Congress which it claims will revolutionise the way cats are cared for in veterinary surgeries
According to the company, plastic cages currently in use tend to harbour germs where cats have made scratches in their surfaces. This cage, however, is the first of its kind to be made from stainless steel, which cats' claws cannot damage.
MDC claims the hygienic Cat Cage will protect animals from disease and infection during their stay in surgery making for happier, healthier patients. The company says the stainless steel Cat Cage is strong, durable and can be flame sterilized. The handles can also be colour-coded, for example, yellow means neuter, red means post-anaesthetic and green means ready to go home. Each stainless steel Cat Cage also comes with a two-year free replacement guarantee.
For more information, visit MDC Exports at BSAVA Congress 2011 on stand 123. All visitors to the stand will receive a complimentary NipLok - the quick-release tourniquet that can be operated one-handed
BSAVA Summit will take place from 16-17 December 2019 at the Royal College of Physicians in London and will involve a series of high-profile keynote speakers and interactive workshops.
The Association says the event will deliver CPD differently to other veterinary meetings, with most sessions run as facilitated workshops to enable delegates to lead and shape discussions.
Confirmed facilitators include RCVS CEO Lizzie Lockett, BEVA President Renate Weller, Director of Clinical Research and Excellence in Practice at VetPartners Rachel Dean and Small Animal Medicine Specialist and Advanced Practitioner in Veterinary Cardiology Dr Kit Sturgess. Each day delegates can choose three out of a total of five workshops. Online forums will be used in the run up to BSAVA Summit to develop ideas and thinking for the workshops before the event.
Day one will focus on ‘The Profession Today’ and topics will include workforce issues, telemedicine, specialism, the future of advanced practitioners and regulation of the profession.
Day two will explore the future of ‘The Profession Tomorrow’ with topics including communication, over-diagnosis, over-treatment and innovation.
On the Monday evening delegates, speakers and facilitators will be able to network at a drinks reception in the library at the Royal College of Physicians.
BSAVA President Sue Paterson said: "We have launched BSAVA Summit to address the rising demand for a space to debate important topics, challenge mindsets and question accepted benchmarks. Following feedback from our members and the profession, Summit will revolutionise veterinary conference norms with a free-flow approach to champion active debate, discussion and reflection.
"There is a growing need to tackle some of the ethical and professional problems that face vets today such as over diagnosis, the role of specialists in practice, and research in practice. Importantly, the format of the discussion forums means that whilst the debate is led by a facilitator, the delegates will drive the agenda to arrive at stimulating and satisfying outcomes. It has been designed to fit with the new outcomes-based approach proposed by the RCVS where veterinary professionals are encouraged to plan their CPD, do their CPD and reflect on what they have learnt.
"The delegates are the key to the event, and Summit should attract people who want to be involved, want to input, want to make a difference and want to help drive the profession forward. I already have people eagerly emailing me wanting news of when the registration goes live.
"Summit aims to help delegates take a hard look at the way they work. Our aim is for each delegate to set themselves personal goals and we will be following up in 3 months to see if they have achieved them."
The BSAVA says that although the Summit is primarily targeted at experienced small animal practitioners, all vets, including equine and large animal practitioners, are welcome to attend.
The full programme will be available and registration will open online on 17th June. BSAVA members will have an opportunity to book advance tickets, with general sale opening two weeks later.
For further information visit www.bsavasummit.com.
The four organisations have written a template letter which anyone can send to any company they see using brachycephalic breeds, such as the Persian, or Scottish Folds, in its marketing materials.
The letter urges companies that use images of cats to work collaboratively with veterinary professionals and pledge to avoid using such breeds in the future.
Dr Nathalie Dowgray, Head of ISFM, said: “Seeing a cute cat in an advertisement can often be a trigger for people to seek out acquiring a cat of that breed without understanding the welfare concerns associated with some pedigree breeds.
"A rise in demand can lead to an increase in breeding practices that result in severe conformational issues and poorer welfare in these breeds.
"We encourage people to download this letter to use when they see breeds of concern being used in advertising, as health is always more important than looks.”
https://icatcare.org/app/uploads/2023/09/ISFM_FECAVA_FVE_UEVPAdvert_Letter.pdf.
Speaking at the MSD Animal Health sponsored National Mastitis Panel, David said that more widespread understanding of the issues is urgently required particularly amongst farmers and cattle vets if real progress is to be made.
David said: "There are some notable examples of veterinary practices that have worked with their clients to eliminate the use of CIAs. These are the exceptions, but they illustrate what is possible. As an industry, we need to speed up the rate of change and make a concerted effort to ensure more responsible use of antibiotics becomes the norm, sooner rather than later."
David quoted the British Cattle Veterinary Association (BCVA) position on the responsible use of medicines, which includes the recommendation of minimal use of third and fourth generation cephalosporins, fluoroquinalones and colistin, with these CIAs being limited to use where it has been demonstrated by sensitivity testing that they are the only suitable option to avoid unnecessary suffering.
"There has been agreement on this position amongst the veterinary associations, farmer organisations and milk buyers, but there needs to be more widespread awareness at producer level, particularly within the vet and farmer relationship.
"Farms with a robust herd health plan, where challenges are reduced, will be in the best position to minimise use of CIAs. This takes time and is most effective where there is good cooperation between the farm and its veterinary practice.
"Achieving a significant reduction in the use of CIAs voluntarily will not only minimise the likelihood of disruptive and potentially punitive legislation but will put our cattle industry on the front foot and strengthen its position in global markets."
The allied professionals that the BVA says should be led by veterinary surgeons include: Registered Veterinary Nurses (RVNs), Official Auxiliaries/ Meat Hygiene Inspectors, embryo transfer technicians, equine dental technicians, foot trimmers, farriers, hydrotherapists, animal behaviourists and veterinary physiotherapists.
To clarify where the responsibility for a patient sits and how it is shared between veterinary surgeons and allied professionals, the new policy statement also calls for:
The regulation of allied professionals to include mandatory veterinary diagnosis and oversight and appropriate access to veterinary records as pre-requisites before treatment;
Clarity on the delegation of duties for RVNs under Schedule 3 of the Veterinary Surgeons Act and protection of the ‘veterinary nurse’ title in legislation;
Consultation with the veterinary profession on any regulatory changes that may arise as a result of technological or other innovation.
British Veterinary Association President Simon Doherty (pictured right) said: "Against an evolving landscape, it’s essential that the veterinary profession keeps pace with change and addresses the challenges and opportunities it presents.
"Vets across sectors have always worked closely with allied professionals. The hub and spoke model acknowledges and clarifies this working relationship with clear lines of accountability and responsibility for the animals under our care. It also emphasises that vets’ right to diagnose, prescribe, and undertake surgical procedures and medical treatments must not be undermined.
"An effective and efficient vet-led team can help deliver better animal health and welfare, improved client care, and more effective use of skills within the veterinary professions. Given the ongoing workforce shortages, a strengthened veterinary workforce also has the potential to ease recruitment and retention concerns for both vets and RVNs and offer improved wellbeing.
"BVA will continue working with professional bodies and organisations to formalise the hub and spoke model, promote the value of regulation, and drive up professional standards."
Step 1: Clean with Oticare, a non-irritating, alcohol-free ceruminolytic ear cleaner formulated to keep ears hygienically clean and restore the normal microbiological balance of the ear canal. The product contains soothing essential oils and propylene glycol to moisturise the lining of the ear canal. It also contains a low concentration of lactic acid and salicylic acid.
Step 2: Treat with Aurimic (polymyxin B, miconazole and prednisolone acetate), which tackles the most common causes of otitis externa; e.g. Staphylococcus spp. and Malassezia. Animalcare says the proven synergistic effects of polymyxin B and miconazole1 allow the reduction of antibiotic concentration and help to minimise the probability of resistance.
Step 3: Prevent with new Oticurant, which Animalcare says is a completely new concept for maintaining healthy ears. Oticurant contains lactic acid to lower the pH, kaolin and lactose to absorb any additional moisture, and special sugars to prevent bacterial adherence to the skin in the ear canal. Oticurant is presented as an odourless mixture of fine powder in single dose sachets.
Tamsin Day, Veterinary Advisor at Animalcare, said: "This is a unique three step approach which we believe will give veterinary professionals more confidence in treating first line ear problems. The Super-earo’s represent a range of three products that together cover cleaning, treatment and prevention. Pet owners will find them easy to administer which will also help to keep these owners compliant to their treatment schedule."
For more information on the Super-earo’s contact your Animalcare representative or visit www.superearos.com
Reference
The company says the masterclass will equip veterinary surgeons with an understanding of how TPLO fits into the range of treatments for one of the commonest causes of serious hindlimb lameness in the adult dog: cranial cruciate ligament failure.
The course will take place on 13 and 14 September at Improve’s HQ, Alexandra House, Swindon, and will be led by Dr Steve Butterworth, MA VetMB CertVR DSAO MRCVS and RCVS Specialist in Small Animal Surgery (Orthopaedics).
Improve’s Veterinary Operations Manager Juliet Pope MRCVS, said: "We are delighted to offer this new masterclass, created for a maximum of ten delegates to ensure true one-to-one tutoring, and we thank the team at Freelance Surgical for supporting its development.
"The combination of lectures and practical sessions led by Steve Butterworth will revise relevant surgical anatomy to enable delegates to undertake TPLO procedures with confidence. We are particularly pleased to be able to offer radiography as an integral part of the course so that delegates can see the results of their new surgical skills before taking them back to their clinics."
The traditional NVQ 'portfolio' system for student veterinary nurses could be phased out from next summer, under draft proposals from the Royal College of Veterinary Surgeons Awarding Body, which has responsibility for the delivery of VN qualifications.
Proposals include an initial year of full-time college study, during which the student does not need to be employed in a Training Practice (TP), the introduction of compulsory farm animal work experience, the phasing out of the separate Equine Veterinary Nursing qualification and a reduction in practice-based assessment.
The catalyst for reviewing the VN qualification came from Ofqual's plans to introduce the new Qualifications and Credit Framework (QCF) from summer next year, which effectively scraps the NVQ in its current form. This gave the RCVS Awarding Body an excellent opportunity to reconsider work-based training for VNs in order to improve its effectiveness and efficiency.
The Awarding Body's proposals, on which comments are invited, aim to reduce bureaucracy for those involved with VN training, increase the number of practices able to take part and improve accessibility of training, ultimately increasing the number of qualified VNs available to the profession.
Under the new proposals, VN work-based training would be a two-year, 70-credit Level 3 qualification, equivalent to 700 hours' learning. The first year of this qualification could be delivered either as a full-time college course, or as a part-time day-release over two years (extending the complete training to three years). The first year would incorporate 25 days' work placement, including small animal, equine and farm animal environments - the first time a compulsory farm animal component has been introduced. This first year of the course could be directly accessed by school leavers, as there is no requirement for them to be employed in a practice.
Students would be employed in a Training Practice for the second 'clinical' year (or third year for part-time students). An online log of practical experience, similar to the Professional Development Phase for new veterinary graduates, would replace the current portfolio, with a more comprehensive end-of-year practical exam. There would no longer be a requirement for practice-based assessors, although students would still need to be supported by an experienced clinical mentor, a role many current assessors may assume.
The economic feasibility of Equine Veterinary Nurse (EVN) training was also considered, with the conclusion that a broader-based primary qualification, with all students carrying out work experience in a range of practice types, was more sustainable.
The number of training practices has long been recognised as a limiting factor in the UK's capacity to train VNs. In addition to standard TPs, proposals have therefore been made for Auxiliary TPs (ATPs). ATPs would be able to employ and train VN students even if they do not have the facilities to provide all of the work experience required: a formal agreement to allow students to fill the gaps at another practice would be in place.
Finally, the proposals include a beefed up range of post-registration education options, allowing Registered Veterinary Nurses to develop, and be recognised, in their own areas of interest. This would help to create a career ladder for RVNs and assist in their retention within the profession.
"The proposals have been developed following a period of consultation with those involved with the delivery of VN training, and with employers," says Jacqui Molyneux, RCVS Council Member and Chairman of the VN Awarding Body.
"Feedback suggests that the current syllabus and training provides competent nurses who are highly regarded within the profession, but that training is overly burdensome for the practices involved. This, coupled with a recognised shortage of both Training Practices and qualified VNs, meant it was appropriate to think more creatively about how the qualification could be delivered. We hope that the draft proposals will be welcomed by both the veterinary nursing and veterinary professions, and would urge people involved to let us know what they think."
The proposals are available on RCVSonline (www.rcvs.org.uk/latestnews ) - please email your comments to Miss Jane Dawson, Project Consultant (jkhdawson@aol.com), by 31 October 2009. It is appreciated that this is a short deadline, however, the time-frame of the QCF is driving development, as is the need to allow colleges and training providers the maximum possible time to develop the new training structure for 2010/11 delivery.
The London Vet Show will next take place on 11th and 12th November 2021 at the ExCeL Center, London.
CloserStill says the decision to cancel was made following several discussions with industry stakeholders, including partners, and considering the significant impact of both international and domestic travel.
Rob Chapman, MD of CloserStill’s veterinary portfolio, said: "COVID-19 has brought enormous pressures and uncertainty to the veterinary sector - both personally and professionally.
"Although the UK Government gave the green light for exhibitions and meetings to start again in October, after examining at the overall market and consultation with our partners, we feel the decision to postpone is in the best interest of the veterinary community.
"Although this news may be disappointing to those looking forward to the London Vet Show, unfortunately the coronavirus situation is continually developing. We want to be as clear and upfront as possible with our community and customers, and after careful consideration, our decision to reschedule was out of caution. As event organisers, the health and safety of our exhibitors, delegates, speakers, staff and supporters, is our number one priority."
"Obviously the postponement decision hasn’t been easy but we firmly believe it’s the right thing to do. We are so fortunate to have support of great partners like the Royal Veterinary College and the British Veterinary Association, along with the exhibitors, speakers and delegates we’ve spoken to so far; everyone has been really understanding. We can’t wait to see you all again virtually soon, and in person in 2021."
"The team and I are eager to continue to provide world-class education to veterinary professionals, to connect and encourage networking to foster the advancement of the veterinary sector. We are developing some great opportunities for the veterinary community come November. We will be announcing more details on this very soon."
A new equine parasite supplement to the online peer-reviewed publication Parasites and Vectors has been published by Fort Dodge.
Entitled "Equine parasites: diagnosis and control - a current perspective," it contains papers on a range of topics including a major European resistance study into key anthelmintic molecules. It is authored by equine parasitology experts and opinion leaders from around the world and was first published in September 2009. It is freely available at http://www.parasitesandvectors.com/
Entitled ‘Managing mitral valve disease from start to finish’, the course will account for four hours’ CPD split into six short bite-size sessions which can be completed at your own pace.
The sessions are presented by Dr Mike Martin MVB DVC MRCVS, and business thought leader, Dr Alison Lambert BVSc CMRS MRCVS. They consist of a practical review of MVD both pre-clinically and clinically and how to diagnose and stage it following the new 2019 American College of Veterinary Internal Medicine (ACVIM) Consensus guidelines.
The course also includes tips on how to treat and manage dogs with MVD with diuretic management; a step-by-step guide to treatment options for acute and long-term management of congestive heart failure and how to troubleshoot problem congestive heart failure cases.
There's also a bonus ‘Communicating Cardiology’ session which looks at how to communicate the heart disease journey to owners.
To register for the course visit www.veterinarywebinars.com/mvd-reg.
Ceva will donate £2 for every veterinary professional completing the course throughout February and March 2021 to Vetlife, which provides support to the veterinary community and their families who have emotional, health or financial concerns.
Remend Corneal Gel is used to aid the healing process of superficial corneal ulcers in dogs, cats and horses while Remend Dry Eye Lubricant Drops is designed to give long-lasting moisture and lubrication for dry eyes in dogs.
https://www.tvm-uk.com
Norbrook Laboratories has launched Closamectin, a parasiticide which the company says will revolutionise cattle farming and parasite control in meat producing animals.
Closamectin Pour-on is a solution which can quite literally be poured onto the back of animals. It simultaneously treats fluke, worms and external parasites. The new product is the culmination of a six year research project costing £3.5 million and involving 80 scientists at the company's headquarters in Newry Co Down.
Norbrook says it will bring immense benefits for farmers whose cattle are often ravaged by parasitic attack. Fluke in particular can have devastating effects both on beef and dairy herds, seriously weakening, and in some cases killing the animals by destroying their livers. At the very least it collectively costs farmers around £17 million per annum by reducing the weight of beef cattle and the milk yields of dairy cows.
Fluke used to be confined to the western parts of Britain, together with Scotland and Ireland, but global warming has seen other parts of the UK experiencing the same mild and wet conditions on which the parasite thrives. Consequently it is on the rise.
Currently fluke is treated by injection or oral drench - both time-consuming and difficult processes for the farmers which can also be stressful for the animals. In contrast pour-on solutions can be applied swiftly and easily with no detrimental impact on cattle.
Norbrook has been awarded licenses for Closamectin Pour-on in both the UK and Ireland. This is a very significant market: the countries have a combined cattle population of 17 million. There are also plans to roll out the product in other countries.
Developing a pour-on to deal with these parasites has baffled scientists for 20 years. Alistair Couper, Norbrook's Chief Vet said: "This is the Holy Grail of farm animal veterinary medicine. It was a highly complex challenge for our research team. They had to develop a product which would treat different conditions simultaneously and have a molecular structure which could be absorbed straight through the skin. This is a ground breaking achievement and a brilliant piece of science"
Lord Ballyedmond, Chairman of Norbrook Laboratories said: "This is a very important milestone for Norbrook and for livestock and farmers worldwide. We have invested heavily in research and development and the results are there for all to see. We are delighted to have beaten other multinationals. We have now developed the world's most effective remedy for parasite control in cattle that our entering the food chain. I am pleased to state that our business has grown this year indigenously at 12% despite the recession, beating our competitors. This tremendous breakthrough is a great testimony to the brilliance of our scientists in Newry and also to our policy of investing in research. "
Virbac has launched Neoprinil, an eprinomectin pour-on solution indicated for use against internal and external parasites in cattle, including gut and lungworms, mange mites, sucking and chewing lice, horn flies and warbles.
Neoprinil has a zero-day withdrawal period in milk and can be administered using the company's Farmpack and Flexibag.
The Farmpack is a backpack which holds a Flexibag of Neoprinil solution. The Flexibag is a bag designed to protect medication and preserve it once it has been opened. The two together were awarded the 2014 PharmaPack Award for Innovative Packaging.
Neoprinil offers a one year stability period once it has first been opened and requires no special conditions for storage. It is presented in 2.5L, 4.5l and 8l pack sizes.
Product Manager for Large Animals Brigitte Goasduf MRCVS said: "A high worm burden can have adverse effects on the herd's productivity and performance and so it is advisable to ensure infected animals are treated as part of a Herd Health Plan. Eprinomectin is a tried and trusted parasiticide and studies confirm that it can have a positive impact on both milk production and on weight gain. Its zero day withdrawal period is a major benefit for dairy farmers.
"With the launch first of Deltanil and, now, Neoprinil, we are reinforcing our commitment to work with veterinary surgeons and farmers to understand the everyday challenges they face and to provide practical, effective solutions. We offer a comprehensive parasiticide range with a dispensing system that sets a new standard for convenience and ease of use."
Written in association with Dr Elinor O’Connor, Senior Lecturer in Occupational Psychology at Alliance Manchester Business School, University of Manchester, the guide is designed for anyone with an interest in the wellbeing of the veterinary team. It provides practical advice to veterinary workplaces on managing stress and promoting wellbeing, alongside examples from the three winning practices of the 2016 MMI/SPVS Wellbeing Awards.
Elinor said: "Addressing stress in veterinary work not only has benefits for the health and wellbeing of each person in the veterinary team, but the business case for reducing work-related stress is clear; stress is associated with poorer performance, increased absenteeism and higher employee turnover. The wellbeing guide provides information about proven techniques for reducing stress at work combined with suggestions for how they might be applied in veterinary workplaces."
Lizzie Lockett, RCVS CEO and Mind Matters Director, said: "Stress at work is an important issue right across the veterinary team. It is sometimes considered just an acceptable part of working in an environment that can be difficult to control, but things can change.
"By making wellbeing a priority practices can support individuals and help their team work better together, and thus provide the best treatment for the animals under their care. This leaflet unpacks some of the root causes of work-related stress and may be of particular interest to practice managers, line managers or health and safety officers."
Good to see that the guide includes a recommendation that practices have measures in place to identify and resolve conflict at work and a clear policy on harassment or bullying, something which research by VetSurgeon.org, VetNurse.co.uk and ex-BSAVA Head of Scientific Policy, Sally Everitt MRCVS found correlated with reduced reports of sustained unpleasant behaviour in practice, a significant source of stress.
The guide can be downloaded here: https://www.vetmindmatters.org/wp-content/uploads/2018/01/MMI-12pp-web.pdf.
It’s very simple.
If you’re a member of VetSurgeon.org, visit the site as soon as possible, and login.
You will then see a red box inviting you to subscribe to a NEW daily or weekly email digest of new questions posted by fellow vets. The box is on the main site home page, and on the community home page.
Subscribe. Today. Now. No time like the present.
Then, whenever you have a question, post it on the site and it will be added to the digest and sent to all subscribed members of the community.
When you get your VetSurgeon Digest, you’ll be presented with a list of the latest questions to skim, both clinical and non-clinical.
Some may catch your eye because you can help, others because you too are interested to know the answer.
Either way, time spent helping others with their questions, or reading answers, counts towards your annual CPD requirement for which you can generate a certificate on the site.
Furthermore, all questions and answers are databased as a searchable knowledge resource for everyone, so whether you’re asking or answering, you’re giving something back to your profession.
So, subscribe now! Did I say that already?
BENEFITS FOR VETERINARY SURGEONS
In short, this offers all the benefits of social media for knowledge-sharing, but with none of the baggage that so often comes with it.
Unite, the largest trade union in the country, has announced that up to 17,000 members of the UK veterinary profession could become members within the next five years, following the establishment of the British Veterinary Union (BVU)The union says it will be able to give veterinary surgeons, veterinary nurses, practice managers, support staff and students in all disciplines, the additional muscle to tackle employment problems in the workplace, such as pay, contracts, bullying and professional development.Unite's General Secretary, Len McCluskey said: 'As a progressive trade union, Unite warmly welcomes BVU into the Unite family. The fact that a highly-regarded profession is looking to Unite for support in employment matters is an indication of the validity and relevance of trade unions in 2011 Britain.' Dr Shams Mir, Chairman, Professional Advisory Committee, British Veterinary Union in Unite said: 'Our biggest challenge will be to change the mindset of our profession to address the deep-trenched problems of working conditions and terms of employment for vets and nurses, and safeguarding their professional status. But, most importantly, we have to overcome the sense of fear amongst veterinary professionals in raising legitimate employment issues.''Veterinary professionals face the same problems in their working lives as any other health professionals, but never before have vets had a trade union to support and represent them. BVU in Unite is a great opportunity for the profession to develop and expand, and is a goal that many have aspired to for years. We believe that up to 17,000 veterinary professionals could join BVU in Unite in the next five years.'Dr Mir said that research has revealed that vets suffer from much higher levels of anxiety and depressive symptoms and they are five times more likely to have suicidal thoughts and four times more likely to commit suicide compared to the general UK population.
He said: 'Sadly, according to the most recent Royal College of Veterinary Surgeons' survey of the profession, nearly half of the responding vets and nurses said that if they had their time again, they would choose a different profession.' 'This is a wake-up call for our profession and we must act to address all the underlying problems leading to this situation.'
Further information is available at: www.bvu.org.uk and www.unitetheunion.org/bvu
Fluboral controls gastro-intestinal nematodes including Ascaridia galli (adult stages), Heterakis gallinarum (adult stages) and Capillaria spp. (adult stages) in chickens and Ascaris suum (adult and L4 intestinal stages) in pigs.
Dechra says Fluboral’s formula allows it to mix in drinking water quickly and easily with five seconds of stirring.
Fluboral has a guaranteed 24-hour stability without sedimentation of the suspension after dilution in drinking water and Dechra says there is no risk of inhomogeneous mixing.
Johnny Wells West, key account manager – pig and poultry at Dechra, said: “Fluboral is a welcome addition to our Solustab range of water-soluble products, providing effortless and efficient parasite control in drinking water to enable farmers and producers to start medication quickly and cost-effectively, as and when needed.”
https://www.dechra.co.uk/products/livestock/prescription/fluboral#Fluboral.
Fort Dodge has released figures today which point to a continued modest slowdown in the UK veterinary sector, being mitigated by a slight increase in average transaction value (the amount a client spends in a year).
Matthew Rowe, Companion Animal Marketing Manager at Fort Dodge, said: "It's been clear for some time that the veterinary sector is being hit by static growth and an increasingly competitive environment. The reduction in turnover being experienced by many practices is primarily down to current clients visiting less often and fewer new clients being attracted."
Key findings of the Fort Dodge Index for the first quarter of 2009 are:
Alan Robinson said: "In the current climate, the only contributor to turnover growth in many practices seems to be a steady rise in the price of professional fees, consultations and surgery. These have continued to push up average transaction values (by 1.4%) and client values (1.2%) in this first quarter of 2009 despite reducing visit frequency. Drug related income increases seem to be driven by a small increase of POM mark-ups in many practices.
"But this alone will not sustain a successful business and, with transaction volumes still falling, the priority for practices is to maintain client footfall despite increasing competition and falling pet ownership. In today's market, retaining clients is a cheaper and more effective way to maintain client and patient numbers so an emphasis on 'bonding' clients though preventative health care and heath maintenance programmes is key.
"We're seeing a steady increase in the number of practices running these programmes but the percentage of pets involved is still woefully low so the message is that practices can and must do better.
Norbrook Laboratories Ltd has launched a new addition to the Loxicom range: Loxicom 0.5mg/ml Oral Suspension for Cats.
Offering alleviation from inflammation and pain, Loxicom Oral Suspension for Cats is billed by Norbrook as 'the new cost-effective treatment for chronic musculo-skeletal disorders in cats that is bio-equivalent to the pioneer.'
The Loxicom range now offers vet practices a choice between 5mg/ml Solution for Injection for Dogs and Cats, 1.5mg/ml Oral Suspension for Dogs and now 0.5mg/ml Oral Suspension for Cats.
Loxicom Oral Suspension for Cats is available in a clear 15ml bottle allowing veterinary surgeons and their clients to monitor product levels and re-order when necessary. The packaging also includes a graduated syringe in 0.5kg increments (from 0.5-10kg) which plugs securely into the bottle allowing accurate, mess-free administration.
Norbrook's small animal range also includes Carprieve, a range of carprofen tablets and injection and Noroclav, the amoxycillin / clavulanic acid range of tablets and injection.
The RCVS Disciplinary Committee has directed that a veterinary surgeon from Berkshire be removed from the Register, following his administration of a prohibited substance to a racehorse and his subsequent attempts to conceal his actions.
At a six-day hearing that concluded yesterday, James Main, a partner in the O'Gorman, Slater, Main & Partners veterinary practice in Newbury, and former lead veterinary surgeon to racehorse trainer Nicky Henderson, faced four charges of serious professional misconduct concerning his treatment of Moonlit Path, a six-year-old mare owned by The Queen.
Three of the charges related to Mr Main breaching British Horseracing Authority (BHA) rules by injecting Moonlit Path with tranexamic acid (TA) on the day she was due to race; the fourth charge related to his dishonest concealment of this treatment in his practice clinical records. Nicky Henderson had himself faced a BHA Inquiry into this case in 2009 and subsequently been sanctioned.
The Committee heard that on 18 February 2009, Mr Henderson's yard requested a veterinary surgeon attend Moonlit Path to administer an injection of Dycenene the following morning. The injection was requested as the mare was prone to exercise-induced pulmonary haemorrhage. Mr Main attended on the morning of 19 February and injected the horse with intravenous tranexamic acid. Moonlit Path raced at Huntingdon later that day, along with the eventual winner, and favourite, Ravello Bay - another horse trained by Mr Henderson. Moonlit Path finished sixth and a urine sample taken from her after the race tested positive for TA.
Of the four charges, Mr Main admitted injecting Moonlit Path with TA on the day she was due to race when he knew this breached the BHA's rule prohibiting any substance other than the horse's usual feed and water being given on race day. However, Mr Main denied knowing that, if tested, a horse would test positive for TA (thereby imposing a strict liability on the trainer); he denied administering a prohibited substance to a horse with the intention to affect that horse's racing performance; and, he denied dishonestly concealing the TA injection by omitting it from his clinical records and referring to it as a 'pre-race check'.
The Committee heard and carefully considered evidence from Mr Henderson and his employees, from BHA investigating officers and its Director of Equine Science and Welfare, from an expert equine physiologist and from Mr Main himself. In its findings, the Committee stated it was "unimpressed by Mr Henderson's evidence and surprised by his apparent lack of knowledge of the rules of racing".
Whilst the Committee accepted Mr Main believed at the time that Moonlit Path would not test positive for TA, it considered he failed to fully inform himself of the medicinal product he was using; especially so as TA does not possess a Marketing Authorisation as a veterinary medicinal product. In so doing, he did not meet his professional obligation to provide Mr Henderson with the information and advice he needed.
The Committee concluded that TA was a prohibited substance and, whilst accepting that Mr Main's concern had solely been for Moonlit Path's welfare, he had actually breached BHA rules by affecting her performance through administering such a substance.
Finally, the Committee found that Mr Main had deliberately concealed the TA injection to Moonlit Path by describing it in his notes as a 'pre-race check' - a protocol developed over several years between the practice and Mr Henderson. Such inaccurate clinical records were in breach of the RCVS Guide to Professional Conduct and led the Committee to conclude he had acted dishonestly. The Committee also found Mr Main "did not act with candour" by claiming to have administered the TA injection the day before the race. On questioning by the Legal Assessor, however, he admitted that he had known that Moonlit Path was racing the same day that he administered the injection.
Professor Sheila Crispin, chairing the Committee, said: "[We] regard it as wholly unacceptable practice that a veterinary surgeon should be party to serious breaches of rules of another regulatory body in the field of animal welfare ... and which go to the very integrity of racing.
"Whilst the findings relate to a single incident, [we] are satisfied that Mr Main's actions amounted to pre-meditated misconduct ... It is highly relevant that Mr Main held positions of responsibility within the racing industry where he was required to uphold the rules and standards of the profession," she added.
Noting Mr Main's "long and hitherto unblemished career as a highly respected equine veterinary surgeon", the Committee accepted Mr Main's evidence that the reason for the administration of tranexamic acid was solely his concern about the welfare of the horse. Nevertheless, it found his evidence was "evasive, lacking in candour and on some aspects of the case his evidence was untrue".
Professor Crispin concluded: "...proven dishonesty has been held to come at the top end of the spectrum of gravity of disgraceful conduct in a professional respect ... Having considered carefully all the mitigation put forward on Mr Main's behalf, [we] have concluded that Mr Main's behaviour was wholly unacceptable and so serious that removal of his name from the Register is required."
Mr Chalkley faced three charges against him. The first was that he failed to identify some or all of the animals tested with Intradermal Comparative Tuberculin (ICT) tests at the farm.
The second charge was that Mr Chalkley had certified that he had carried out ICT tests on 279 animals at the farm and recorded the results on the accompanying paperwork but had, in fact, not adequately identified some or all of the 279 animals and had fabricated the skin thickness measurements recorded for some of them.
In addition, the charge alleged that Mr Chalkley’s conduct was dishonest, misleading and risked undermining government testing procedures designed to promote public health.
The third charge was that between June 2011 and September 2018, Mr Chalkley received payment of approximately £20,000 for ICT tests when, as a result of his conduct in relation to ICT tests at the farm, he was not entitled to such payment.
At the outset of the hearing Mr Chalkley admitted the first charge, that he had not adequately identified some of the animals.
On the third day of the hearing, during his evidence to the Committee, he admitted that his certification of the ICT testing was therefore misleading.
He denied the rest of the charges including that his conduct had been dishonest and that it had risked undermining government testing procedures designed to promote public health.
In considering the charges against Mr Chalkley, the Committee heard that discrepancies regarding the tests that were carried out on the farm in March 2018 were originally raised by the Animal and Plant Health Agency (APHA), on whose behalf Mr Chalkley carried out ICT testing in his capacity as an Official Veterinarian.
When Mr Chalkley gave evidence during the hearing, he explained that he had taken over TB testing for the farm in 2008 and that working conditions on the farm had been difficult throughout the whole period 2008 to 2018. He stated that due to the harsh weather conditions of early 2018, TB testing was difficult, and that the farmer needed to complete the test by March 2018 to avoid a financial penalty.
Mr Chalkley explained that one of the reasons for there being limited time available for him to carry out the test within the time required by the farmer was that he was due to provide veterinary cover at the Cheltenham races the following week and he was unable to find anyone else to cover the tests. Mr Chalkley also explained that during the tests on 5 and 8 March there had been limited farmhands available to assist in processing the cattle through the tests.
In the course of being asked questions by counsel for the RCVS, Mr Chalkley accepted that he had failed to identify some 45% of the animals he had injected on 5 March 2018 and had, in respect of each of the skin thickness measurements for those animals, randomly chosen a figure that he believed would be appropriate based on the breed, age and sex of the animal.
The APHA guidelines state that specific measurements should be made and recorded for each individual animal using callipers. Mr Chalkley said that he could not remember seeing the “pop-up” declaration which appeared when submitting the results to the APHA online and had never read it. He stated that he was not aware that he was making a declaration. However, he accepted that as an Official Veterinarian he was confirming that he had carried out the test properly. While he agreed that he knew that the test contained inaccuracies, he did not accept that he was being dishonest when he submitted the results.
Having considered all the evidence put forward by the RCVS and Mr Chalkley in his own defence, the Committee found that Mr Chalkley had acted dishonestly in deliberately choosing not to take the measurements on 5 March and had instead submitted fabricated alternatives, and so risked undermining public health by failing to carry out his duties as an OV.
The Committee also concluded that Mr Chalkley had been acting dishonestly, as he knew that he was submitting the test results as if they were the authentic outcome of a properly conducted test when in reality, they were no such thing.
The Committee did not accept Mr Chalkley’s evidence that he was unaware of the declaration which accompanied the submission of the test outcome. The Committee therefore found both the first and second charges proved.
In respect of the third charge the Committee found that this was not proven noting that the RCVS had not disproved Mr Chalkley’s explanation regarding his reasons for returning the £20,000 in fees he had received for carrying out TB testing at the farm from the APHA since 2011.
The Committee then considered whether the first two charges, both of which had been found proven, amounted to serious professional misconduct.
Ian Arundale, chairing the Committee and speaking on its behalf, said: “The Committee was prepared to accept that the respondent considered the risk arising from his actions as negligible. Nonetheless, in the Committee’s assessment a real risk existed due to the respondent’s actions and it was precisely the risk which the authorised testing procedure was designed to negate. The simple fact is the respondent could not be sure that each animal he assessed on 8 March 2018 had also been seen by him on 5 March 2018.
“However, the wider point with which the Committee was concerned related to the importance of any member of the profession or public being able to rely absolutely on the integrity of veterinary certification. Those parts of the Code and supporting guidance [concerning certification]… were unequivocal. It was very difficult to conceive of circumstances in which it could ever be justifiable to certify the outcome of a test which had not, in fact, been conducted in a way which was demonstrably valid and reliable. Such conduct was bound to be regarded as disgraceful by members of the profession and the general public.
“Honesty is the bedrock of appropriate certification and the Code and Guidance for the Disciplinary Committee is also unequivocal. Dishonesty in professional practice is always an extremely serious matter and the respondent’s responsibilities in the discharge of his functions as an Official Veterinarian were clear. On this occasion those responsibilities had been compromised.
“For these reasons, the Committee has come to the conclusion that the respondent’s conduct in relation to the facts found proved was disgraceful conduct in a professional respect.”
The Committee then went on to consider the sanction for Mr Chalkley.
The Committee heard oral evidence in mitigation, including from a former colleague who had worked with him in practice since 2006, as well as receiving a large number of written testimonials from various sources that attested to his honesty, integrity, willingness to help others, and charitable work in support of animal welfare.
Mr Chalkley’s counsel, in mitigation, highlighted his long and previously unblemished career, and characterised the conduct as an inexcusable but explicable error of judgement that was entirely isolated and out-of-character. Mr Chalkley’s counsel added that he had not done anything that he thought was seriously wrong, and there was no evidence that any harm had been done and that any risk to public health was not serious.
The Committee accepted that the conduct was isolated and out-of-character and that, furthermore, Mr Chalkley had made early and frank admissions to the APHA and that he had displayed a degree of insight, although the Committee was less confident that he truly understood the seriousness of the potential consequences of his dishonest conduct.
The Committee took into account the aggravating factors, including Mr Chalkley’s breach of trust of his position as an OV, the undermining of the integrity of veterinary certification, dishonesty and the potential public health impacts of his conduct.
Ian Arundale added: “The Committee considered that, having regard to the mitigating features which it had identified, a suspension order would be sufficient to send to the profession and the public a clear signal about the importance to be attached to accurate certification. The Committee considered that in the particular circumstances of this case, a period of three months suspension would be sufficient to achieve this objective.”
The full findings for the case can be found at: www.rcvs.org.uk/disciplinary